深部静脈疾患治療機器市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

深部静脈疾患治療機器市場は、2023年に10億9,000万米ドルと評価され、2024年には11億7,000万米ドルに達すると予測され、CAGR 7.64％で成長し、2030年には18億3,000万米ドルに達すると予測されています。

深部静脈疾患（DVD）治療機器には、深部静脈血栓症（DVT）や慢性静脈不全（CVI）など、深部静脈系に影響を及ぼす疾患の診断と治療を目的としたさまざまな医療機器や技術が含まれます。これらの機器の必要性は、座りっぱなしのライフスタイルの増加、人口の高齢化、静脈障害のリスクを高める心血管疾患の増加によってもたらされています。治療対象は病院、専門クリニック、在宅ヘルスケアに及び、個々の患者に合わせた治療アプローチの重要性が強調されています。エンドユーザーには、ヘルスケアプロバイダー、医療専門家、低侵襲治療ソリューションを求める患者などが含まれます。市場に影響を与える重要な成長要因は、機器技術の進歩、早期診断に対する意識の高まり、非侵襲的治療オプションに対する需要です。新規治療法の出現と有利な規制状況は、技術革新と成長の潜在的機会をもたらします。市場参入企業は、有効性と患者の転帰を高める次世代静脈デバイスを開発するために、戦略的提携を模索し、研究開発に投資することができます。しかし、高い治療費、厳しい規制要件、熟練した専門家の不足といった課題が、市場拡大の障害となる可能性があります。発展途上地域の経済的制約は、成長の可能性をさらに阻害します。こうした課題を軽減するため、企業は費用対効果の高い製品開発や、専門家養成を強化する教育プログラムに注力できると思われます。技術革新の機が熟している分野には、ウェアラブル・モニタリング機器、人工知能支援診断、より迅速で全人的な治癒プロセスを促進する生物学的に統合された治療ソリューションなどがあります。主要な研究努力は、DVDの分子メカニズムを理解し、現在の機器の生体適合性と機能を強化することに軸足を置くことができます。市場情勢は競争的でダイナミックであり、急速な技術進歩と進化するヘルスケア需要によって特徴付けられ、市場プレーヤーは新たな機会を活用しながら競争力を維持するために機敏で先見的であることが求められています。

市場力学：急速に進化する深部静脈疾患治療機器市場の主要市場インサイトを公開

深部静脈疾患治療機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 深部静脈疾患の世界の増加
  • 予防機器に対する意識の高まり
• 市場抑制要因
  • 代替治療オプションの利用可能性
• 市場機会
  • 深部静脈疾患治療器具の継続的な研究開発活動
  • 個別化血管テントと間欠的空気圧迫装置の開発
• 市場の課題
  • 熟練した専門家の不足

ポーターのファイブフォース：深部静脈疾患治療機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：深部静脈疾患治療機器市場における外部からの影響の把握

外部マクロ環境要因は、深部静脈疾患治療機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析深部静脈疾患治療機器市場における競合情勢の把握

深部静脈疾患治療機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス深部静脈疾患治療機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、深部静脈疾患治療機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨深部静脈疾患治療機器市場における成功への道筋を描く

深部静脈疾患治療機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で深部静脈疾患の発生率が増加
    • 予防装置に関する意識の高まり
  • 抑制要因
    • 代替治療オプションの利用可能性
  • 機会
    • 深部静脈疾患治療機器の研究開発活動を継続中
    • パーソナライズされた血管テントと間欠的空気圧迫装置の開発
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 深部静脈疾患治療機器市場：タイプ別

• 圧縮装置
• 末梢血管ステント
• 血栓除去および血栓溶解装置

第7章 深部静脈疾患治療機器市場：エンドユーザー別

• 外来手術センター
• 病院・クリニック

第8章 南北アメリカの深部静脈疾患治療機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の深部静脈疾患治療機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの深部静脈疾患治療機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acandis GmbH
• Alma Lasers GMBH
• Andratec GmbH
• AngioDynamics, Inc.
• Becton, Dickinson, and Company
• Biolitec AG
• Boston Scientific Corporation
• Cardinal Health
• Imperative Care
• Innova Vascular, Inc.
• Johnson & Johnson Medical NV
• Kavya Pharma
• Koninklijke Philips N.V.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Nipro Corporation
• Penumbra Inc.
• Stryker Corporation
• Surmodics, Inc.
• Teleflex Incorporated
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COMPRESSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY THROMBECTOMY & THROMBOLYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Deep Venous Disease Treatment Devices Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 1.83 billion by 2030.

Deep Venous Disease (DVD) Treatment Devices encompass a range of medical devices and technologies aimed at diagnosing and treating conditions affecting the deep venous system, including deep vein thrombosis (DVT) and chronic venous insufficiency (CVI). The necessity for these devices is driven by the increasing prevalence of sedentary lifestyles, aging populations, and rising incidences of cardiovascular diseases, which heighten the risk for venous disorders. Applications extend to hospitals, specialty clinics, and home healthcare settings, emphasizing the importance of tailored treatment approaches. End-users include healthcare providers, medical professionals, and patients seeking minimally invasive therapeutic solutions. Significant growth factors influencing the market are advancements in device technology, growing awareness on early diagnosis, and the demand for non-invasive treatment options. The emergence of novel therapies and favorable regulatory landscapes present potential opportunities for innovation and growth. Market participants can explore strategic collaborations and invest in R&D to develop next-generation venous devices that enhance efficacy and patient outcomes. However, challenges such as high treatment costs, stringent regulatory requirements, and the dearth of skilled professionals may pose hurdles to market expansion. Economic constraints in developing regions further impede growth potential. To mitigate these challenges, companies could focus on cost-effective product development and educational programs to bolster professional training. Areas ripe for innovation include wearable monitoring devices, artificial intelligence-assisted diagnostics, and biologically integrated treatment solutions that promote faster and more holistic healing processes. Key research efforts can pivot towards understanding the molecular mechanisms of DVD and enhancing current device biocompatibility and function. The market landscape is competitive and dynamic, characterized by rapid technological advancements and evolving healthcare demands, mandating market players to stay agile and forward-thinking to maintain a competitive edge while tapping into emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Venous Disease Treatment Devices Market

The Deep Venous Disease Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of deep vein diseases across the world
  • Rising awareness about preventative devices
• Market Restraints
  • Availability of alternative treatment options
• Market Opportunities
  • Ongoing research and development activities for deep vein disease devices
  • Development of personalized vascular tents and intermittent pneumatic compression devices
• Market Challenges
  • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Deep Venous Disease Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Venous Disease Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Venous Disease Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Venous Disease Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Venous Disease Treatment Devices Market

A detailed market share analysis in the Deep Venous Disease Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Venous Disease Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Venous Disease Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Venous Disease Treatment Devices Market

A strategic analysis of the Deep Venous Disease Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Venous Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Alma Lasers GMBH, Andratec GmbH, AngioDynamics, Inc., Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Cardinal Health, Imperative Care, Innova Vascular, Inc., Johnson & Johnson Medical NV, Kavya Pharma, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra Inc., Stryker Corporation, Surmodics, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Deep Venous Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Compression Device, Peripheral Vascular Stent, and Thrombectomy & Thrombolysis Device.
• Based on End User, market is studied across Ambulatory Surgical Centres and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of deep vein diseases across the world
    • 5.1.1.2. Rising awareness about preventative devices
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative treatment options
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for deep vein disease devices
    • 5.1.3.2. Development of personalized vascular tents and intermittent pneumatic compression devices
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Deep Venous Disease Treatment Devices Market, by Type

• 6.1. Introduction
• 6.2. Compression Device
• 6.3. Peripheral Vascular Stent
• 6.4. Thrombectomy & Thrombolysis Device

7. Deep Venous Disease Treatment Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centres
• 7.3. Hospitals & Clinics

8. Americas Deep Venous Disease Treatment Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Venous Disease Treatment Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Venous Disease Treatment Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Alma Lasers GMBH
• 4. Andratec GmbH
• 5. AngioDynamics, Inc.
• 6. Becton, Dickinson, and Company
• 7. Biolitec AG
• 8. Boston Scientific Corporation
• 9. Cardinal Health
• 10. Imperative Care
• 11. Innova Vascular, Inc.
• 12. Johnson & Johnson Medical NV
• 13. Kavya Pharma
• 14. Koninklijke Philips N.V.
• 15. Medtronic PLC
• 16. Merit Medical Systems, Inc.
• 17. Nipro Corporation
• 18. Penumbra Inc.
• 19. Stryker Corporation
• 20. Surmodics, Inc.
• 21. Teleflex Incorporated
• 22. Terumo Corporation